Switching to biosimilars in the treatment of rheumatic diseases.
Yoo, Dae Hyun
Switching to biosimilars in the treatment of rheumatic diseases. [electronic resource] - Expert review of clinical immunology 07 2018 - 557-571 p. digital
Publication Type: Journal Article; Review
1744-8409
10.1080/1744666X.2018.1490178 doi
Animals
Antirheumatic Agents--therapeutic use
Biosimilar Pharmaceuticals--therapeutic use
Drug Approval
Drug Substitution
Evidence-Based Medicine
Expert Testimony
Humans
Randomized Controlled Trials as Topic
Rheumatic Diseases--drug therapy
Switching to biosimilars in the treatment of rheumatic diseases. [electronic resource] - Expert review of clinical immunology 07 2018 - 557-571 p. digital
Publication Type: Journal Article; Review
1744-8409
10.1080/1744666X.2018.1490178 doi
Animals
Antirheumatic Agents--therapeutic use
Biosimilar Pharmaceuticals--therapeutic use
Drug Approval
Drug Substitution
Evidence-Based Medicine
Expert Testimony
Humans
Randomized Controlled Trials as Topic
Rheumatic Diseases--drug therapy